Lead researcher
Dr Jake Shortt, Prof Ricky Johnstone
Institution
Gene Regulation Laboratory, Peter MacCallum Cancer Centre
Years funded
2015-2017
Lymphomas
are cancers of the white blood cells. Some of the worst lymphomas are caused by
a gene called ‘MYC'. Recent developments have produced a new drug-class that
inhibits MYC. These ‘MYC inhibitors' can kill lymphomas but some cells survive
and become resistant. Our research will generate and isolate resistant
lymphomas and work out how they have developed resistance. This information
will then be used to test new drug combinations to prevent resistance happening
in patients.
Funding Body
Cancer Council Research Grant
Funding
$99,268 in 2015, $99,805 in 2016 and $100,000 in 2017